Ooni Koda
  1. Home
  2. /
  3. Newsfeed
  4. /
  5. Biofarm records a net profit of 77 million...

Biofarm records a net profit of 77 million lei in 2023, up 9% compared to 2022

March 4, 2024

Biofarm, (stock symbol BIO), one of the most important drug manufacturers in Romania, ended 2023 with a net profit of about 77 million lei, up 9% from the previous year and a turnover of approx. 280 million lei, according to preliminary results (unaudited).

 

"In 2023, we successfully implemented cost optimization strategies, focusing in particular on two of our company values: performance and end-consumer care. In doing so, we were able to identify effective ways to control our expenses, even in the context of rising raw material and packaging prices. The Consumer Healthcare category in Romania is becoming more and more competitive year by year, marked also by a slight decline in volumes in 2023 compared to 2022. However, we ended 2023 managing to consolidate our position on the market, with a positive evolution of the volume market share and to contribute positively on the quality of life of patients and consumers in Romania", said Cătălin Vicol, Biofarm CEO.

 

Biofarm continued to strengthen its market share in the Consumer Healthcare (CHC) segment, and ended 2023 in second position in terms of number of units sold.

 

The company dominates in value in 6 key categories across brands: Bixtonim, Triferment, Colebil, Extravalerianic, Carmol and Carbocit. In addition, Biofarm is the volume leader in no less than 8 categories, highlighting the outstanding performance of the brands Bixtonim, Colebil, Triferment, Sennalax, Extravalerianic, Carmol, Carbocit and Nervocalmin. These results confirm the success of Biofarm's approach and commitment to innovation. Through its achievements, the company continues to establish itself as a trusted player in Consumer Healthcare, offering effective and affordable solutions to consumers.

 

Biofarm has two drug factories in Bucharest and a product testing and development unit, and its portfolio of over 100 products covers the most important therapeutic areas of the Consumer Healthcare division (digestive & metabolic, respiratory & ORL, cardiovascular & circulatory, nervous system). Constant innovation in the development of new products is one of the fundamental elements for Biofarm's expansion and strengthening its position among the leaders in the pharmaceutical industry.

The information provided by KomuniK

The text of this article has been partially taken from the publication:
https://komunik.ro/biofarm-records-a-net-profit-of-77-million-lei-in-2023-up-9-compared-to-2022/
Read in full - click here
Artificial snow production begins in Poiana Brașov ahead of ski season

The City Hall of Brașov announced that artificial snow production has started in Poiana Brașov, preparing the slopes for the upcoming ski season. Snow cannons and lances were activated on Friday morning, November 15, as temperatures reached -6 degrees Celsius at the top of Postăvaru Massif. “Considering the favorable weather conditions, with low temperatures in […]

European Commission takes Romania, Bulgaria to court for failing to treat wastewater

On Thursday, November 14, the European Commission decided to refer Romania and Bulgaria to the Court of Justice of the European Union for failing to fully comply with the obligations regarding collection and treatment established in the Urban Waste Water Treatment Directive. Untreated or uncollected wastewater can endanger human health and pollute lakes, rivers, soil, […]

Big lottery prize of almost EUR 10 mln won in Romania

The big prize of the Romanian Lottery's 6/49 game was won on Thursday, November 14.  The winning ticket, which brought almost EUR 9.6 million (RON 47.7 million) to the lucky player, was played at an agency in Galaţi and featured 630 combinations and one "noroc" play, costing a total of RON 4,413, the Romanian Lottery […]

Sphera Franchise Group reports, in the first 9 months, a net normalized profit increase of 66% compared to 2023, with record sales of over RON 1.14 billion

New record: sales of RON 1.14 billion in the first 9 months, higher by 6.4% compared to the same period in 2023 Normalized net profit increase of 66.3% compared to 9 months 2023, to RON 71.4 million, almost 90% of the normalized profit of the entire previous year EBITDA margin reached 11.3% in the first […]

Romania's interior minister expects progress on full Schengen accession after November 22 talk with Karner

Romania's interior minister, Cătălin Predoiu, expressed cautious optimism about the country's prospects for full Schengen accession following a meeting scheduled for November 22 with Austrian interior minister Gerhard Karner.  Speaking on local news channel Antena 3, Predoiu stated that "the pieces are quite well placed" for progress on accession with land borders,

Romgaz floats its 5-year, 4.75% EUR 500 mln FX bond at Bucharest Exchange

Romgaz (BVB: SNG), the largest producer and main supplier of natural gas in Romania, will list its first bond issue, worth EUR 500 million and aimed to finance the Neptun Deep offshore gas project, on the Bucharest Stock Exchange on November 19. In October, Romgaz issued the first EUR 500 million tranche of a EUR […]